Topic: mRNA

In this Review, we discuss barriers to including pregnant women in trials, assess regulatory and pharmacovigilance readiness, and identify health-system and vaccine-confidence risks to equitable rollout.

An extraordinary effort will be needed to sustain confidence in vaccines, given the unprecedented level of misinformation being propagated about them, even from official sources, writes Heidi J. Larson, Director of the Vaccine Confidence Project.

We conducted a social listening analysis to assess attitudes towards mRNA vaccines and therapeutics on Twitter from June 2022 to May 2023. Our findings reveal widespread negative sentiment and a global lack of confidence in mRNA vaccines and therapeutics, with frequent discussions of severe vaccine side effects, rumors, and misinformation.

We conducted a social listening analysis to assess attitudes towards mRNA vaccines and therapeutics on Twitter from June 2022 to May 2023.